While oral semaglutide produces meaningful weight loss, injectable formulations consistently outperform, and more patients discontinue oral semaglutide due to gastrointestinal side effects
doi: 10.1371/journal.ppat.1013456 90 WangS.ZhaoY.BreslawecA
What the Science Says The short answer: BPC-157 appears to be safe in animal models and anecdotal human use , but definitive safety conclusions for long-term human use have not yet been established
But individual timing and use should be discussed with a healthcare provider
Some sites offer the bacteriostatic water and syringes people need to mix their own dosages at home
Read more This material is based on the article: GLP-1 Receptor Agonists in Chronic Inflammatory Skin Diseases: Immunometabolic Mechanisms and Translational Perspectives Authors: Klara Andrzejczak, Emilia Kucharczyk, Matylda Korgiel, Justyna Drozdowska, Joanna Maj, Magorzata Ponikowska Pharmaceutics, 2026.